Original-Research: MLP SE - from NuWays AG
Classification of NuWays AG to MLP SE
Q1 slightly softer than expected, key drivers remain intact Topic: MLP released Q1 results which came in slightly lower than expectations on sales and EBIT, but nevertheless show the anticipated RE recovery, which should pose the FY’25 guidance well in reach. Sales grew by 6% yoy to € 301m, mainly driven by Wealth (+8% yoy to € 125m), Life & Health (+10% yoy to € 64m) and P&C (+5% yoy to € 102m), whereas sales from the nearly stopped RE development came in as expected (-92% yoy to € 0.3m). EBIT came in at € 37.8m with a 12.6% margin (-0.4pp yoy), lower than expected (eNuW: € 42m) mainly driven by higher than initially expected commission expenses (€ 141m, +11% yoy), especially in banking and RE brokerage. Also, only minor performance fees of € 0.4m had a little impact on Q1’s EBIT (EBIT effect: € 0.3m vs. € 2.5m in Q1’24, eNuW). Excluding this effect, underlying profitability increased again by 0.2pp yoy to a 12.5% EBIT margin ex performance fees, highlighting the robust business model, also in times of economic uncertainty and capital market volatility. On a segmental basis, the absolute yoy changes in EBIT came from Financial Consulting (+ € 2.7m), Deutschland.Immobilien (€ +2.3m) and DOMCURA (€ +0.6m), which cushioned the decline at Banking (€ -2m, due lower net interest income and higher commission expenses) and FERI (€ -2.6m, due to almost no performance fees). Furthermore, AuMs remained largely stable at € 62.8bn (-0.5% qoq, of which -1.9% performance related and +1.4% from very strong net capital inflows of € 900m), which compares well against the market development (e.g. S&P 500: - 4.6% qoq). The RE recovery is going on, as sales from RE brokerage increased from a low level by 158% yoy to € 7.9m. A key highlight, was the rising brokerage margin (sales in % of brokered volume), which rose by 2.5pp yoy. This effect should continue throughout the year, where the sales of new higher margin brokerages, which is contracted right now, are recognized. Additionally, a few old and new development projects, which are seen to generate RE development sales to the tune of € 5-6m in FY’25e (eNuW), should altogether lead to an EBIT break-even of the Deutschland.Immobilien segment, in our view. Against this backdrop, the FY’25 guidance seems well achievable, even in the event of only minor, but highly profitable performance fees. Therefore, we reiterate our BUY recommendation with an unchanged PT of € 13.00, based on SOTP and FCFY’25e. You can download the research here: http://www.more-ir.de/d/32624.pdf For additional information visit our website: https://www.nuways-ag.com/research-feed Contact for questions: NuWays AG - Equity Research Web: www.nuways-ag.com Email: research@nuways-ag.com LinkedIn: https://www.linkedin.com/company/nuwaysag Adresse: Mittelweg 16-17, 20148 Hamburg, Germany ++++++++++ Diese Meldung ist keine Anlageberatung oder Aufforderung zum Abschluss bestimmter Börsengeschäfte. Offenlegung möglicher Interessenskonflikte nach § 85 WpHG beim oben analysierten Unternehmen befinden sich in der vollständigen Analyse. ++++++++++
The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. |
2139092 16.05.2025 CET/CEST
P R O D U C T S U G G E S T I O N S
The information presented here has been provided by our content partner EQS-Group. The originator of the news is the respective issuer, the company relating to the news, a publication service provider (press or information agency) which uses the distribution service of EQS to transmit company news to shareholders, investors, investors or interested parties. The original publications and other company-relevant information can be found at eqs-news.com.
The information you can access does not constitute investment advice. The presentation of our cooperation partners, where the implementation of investment decisions would be possible depending on the individual risk profile, is solely at the discretion of the person using the service. We only present companies of which we are convinced that the range of services and customer service will satisfy discerning investors.
If you are considering leverage products, familiarise yourself with the typical characteristics of the financial instruments beforehand. Take the time to determine the risk content of the planned investment before making an investment decision. Bear in mind that a total loss cannot be ruled out with leverage products.
For newcomers to the subject, we offer various options in both the training and the tools section, through which you can train theoretical knowledge and practical experience and thus improve your skills. The offer ranges from participation in webinars to personal mentoring. The range is continuously being expanded.
1 Lab features are usually functionalities that emerge from the think tank of the investor community. In the early stages, these are experimental functionalities whose development process is largely determined by use and the resulting feedback from the community. When integrating external services or functionalities, the functionality can only be guaranteed to the extent that the individual process elements, such as interfaces, interact with each other.